{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:49:56Z","timestamp":1791402596382,"version":"4.3.3"},"reference-count":31,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Down's syndrome Association","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>A proportion of young people with Down syndrome (DS) experience unexplained regression that severely impacts on their daily lives. While this condition has been recognised by clinicians, there is a limited understanding of causation and an inconsistent approach to diagnosis and treatment. Varied symptomology and little knowledge of the cause of this regression have impacted on clinician\u2019s ability to prevent or manage this condition. The purpose of this review was to examine the current evidence surrounding unexplained regression in adolescents and young adults, and to establish patterns that may be of use to clinicians, as well as raising awareness of this condition. Four areas were specifically reviewed, (1) terminology used to refer to this condition, (2) the symptoms reported, (3) potential trigger events and, (4) treatments and prognosis. A variety of terminology is used for this condition, which has constrained past attempts to identify patterns. An extensive number of symptoms were reported, however sleep impairment, loss of language and distinct changes in personality and behaviour, such as disinterest and withdrawal, were among the most frequently seen. Life events that were tentatively associated with the onset of a regressive period included a significant change in environmental circumstances or a transition, such as moving home or leaving school. Prognosis for this condition is relatively positive with the majority of individuals making at least a partial recovery. However, few patients were found to make a full recovery to their previous level of functioning and serious adverse effects could persist in those who have made a partial recovery. This is an under-researched condition with significant impacts on people with DS and their families. There are no established treatments for this condition and there is relatively little recognition in the research community. Further studies that focus on the prevention and treatment of this condition with controlled treatment trials are needed.<\/jats:p>","DOI":"10.3390\/brainsci11091197","type":"journal-article","created":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T21:45:57Z","timestamp":1631483157000},"page":"1197","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Systematic Review of Unexplained Early Regression in Adolescents and Adults with Down Syndrome"],"prefix":"10.3390","volume":"11","author":[{"given":"Madeleine","family":"Walpert","sequence":"first","affiliation":[{"name":"Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Cambridge CB2 8AH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Zaman","sequence":"additional","affiliation":[{"name":"Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Cambridge CB2 8AH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Holland","sequence":"additional","affiliation":[{"name":"Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Cambridge CB2 8AH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Down Syndrome","volume":"6","author":"Antonakaris","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1002\/ajmg.a.32581","article-title":"Setting a public health research agenda for Down syndrome: Summary of a meeting sponsored by the centers for disease control and prevention and the national down syndrome society","volume":"146","author":"Rasmussen","year":"2008","journal-title":"Am. J. Med. Genet. Part. A"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s11689-015-9101-1","article-title":"Psychiatric disorders in adolescents and young adults with Down syndrome and other intellectual disabilities","volume":"7","author":"Dykens","year":"2015","journal-title":"J. Neurodev. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41436-019-0706-8","article-title":"Unexplained regression in Down syndrome: 35 cases from an international Down syndrome database","volume":"22","author":"Santoro","year":"2019","journal-title":"Genet. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0022-510X(89)90019-1","article-title":"The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down\u2019s syndrome","volume":"89","author":"Mann","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jalz.2015.07.490","article-title":"The pattern of amyloid accumulation in the brains of adults with Down syndrome","volume":"12","author":"Annus","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2012","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e20192939","DOI":"10.1542\/peds.2019-2939","article-title":"Down Syndrome Disintegrative Disorder: A Clinical Regression Syndrome of Increasing Importance","volume":"145","author":"Rosso","year":"2020","journal-title":"Pediatrics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3736\/jcim20090918","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"7","author":"Moher","year":"2009","journal-title":"J. Chin. Integr. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0891-4222(95)00015-F","article-title":"Major depression in a small group of adults with down syndrome","volume":"16","author":"Myers","year":"1995","journal-title":"Res. Dev. Disabil."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/19315864.2011.599917","article-title":"Adolescents and Young Adults With Down Syndrome Presenting to a Medical Clinic With Depression: Phenomenology and Characterization Using the Reiss Scales and Aberrant Behavior Checklist","volume":"4","author":"Capone","year":"2011","journal-title":"J. Ment. Health Res. Intellect. Disabil."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/NDT.S32767","article-title":"Acute neuropsychiatric disorders in adolescents and young adults with down syndrome: Japanese case reports","volume":"8","author":"Akahoshi","year":"2012","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/DBP.0b013e31828b2b42","article-title":"Developmental regression, depression, and psychosocial stress in an adolescent with Down syndrome","volume":"34","author":"Stein","year":"2013","journal-title":"J. Dev. Behav. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/ajmg.a.36052","article-title":"Adolescents and young adults with down syndrome presenting to a medical clinic with depression: Co-morbid obstructive sleep apnea","volume":"161","author":"Capone","year":"2013","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/NDT.S77307","article-title":"Catatonia in down syndrome; a treatable cause of regression","volume":"11","author":"Ghaziuddin","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/ajmg.a.37674","article-title":"Rapid clinical deterioration in an individual with Down syndrome","volume":"170","author":"Jacobs","year":"2016","journal-title":"Am. J. Med. Genet. Part. A"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.braindev.2015.06.006","article-title":"Effects of donepezil and serotonin reuptake inhibitor on acute regression during adolescence in Down syndrome","volume":"38","author":"Tamasaki","year":"2016","journal-title":"Brain Dev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mircher, C., Cieuta-Walti, C., Marey, I., Rebillat, A.-S., Cretu, L., Milenko, E., Conte, M., Sturtz, F., Rethore, M.-O., and Ravel, A. (2017). Acute Regression in Young People with Down Syndrome. Brain Sci., 7.","DOI":"10.3390\/brainsci7060057"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/dmcn.14127","article-title":"Immunotherapy in selected patients with Down syndrome disintegrative disorder","volume":"61","author":"Cardinale","year":"2018","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2147\/NDT.S210613","article-title":"Catatonia in down syndrome: Systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients","volume":"15","author":"Miles","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/DBP.0b013e318165c78d","article-title":"Difference in age at regression in children with autism with and without Down syndrome","volume":"29","author":"Castillo","year":"2008","journal-title":"J. Dev. Behav. Pediatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/0883073814554654","article-title":"Down syndrome disintegrative disorder: New-onset autistic regression, dementia, and insomnia in older children and adolescents with down syndrome","volume":"30","author":"Worley","year":"2015","journal-title":"J. Child. Neurol."},{"key":"ref_23","first-page":"101","article-title":"Disintegrative syndrome in young adults","volume":"19","author":"Prasher","year":"2002","journal-title":"Int. J. Psychiatr. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1192\/bjp.165.3.399","article-title":"Clinical Features and Diagnostic Criteria of Depression in Down Syndrome","volume":"165","author":"Cooper","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archneurol.2009.45","article-title":"Hashimoto encephalopathy and down syndrome","volume":"66","author":"Brodtmann","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref_26","first-page":"183","article-title":"Mitochondrial disease clinical manifestations: An overview","volume":"53","author":"Mattman","year":"2011","journal-title":"Br. Columbia Med. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","article-title":"Intrinsic defect of the immune system in children with Down syndrome: A review","volume":"156","author":"Kusters","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s11689-020-9309-6","article-title":"Psychiatric illness and regression in individuals with Phelan-McDermid syndrome","volume":"12","author":"Kohlenberg","year":"2020","journal-title":"J. Neurodev. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e20191490","DOI":"10.1542\/peds.2019-1490","article-title":"Subacute Neuropsychiatric Syndrome in Girls With SHANK3 Mutations Responds to Immunomodulation","volume":"145","author":"Bey","year":"2020","journal-title":"Pediatrics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1017\/S0033291707002504","article-title":"The phenomenology and diagnosis of psychiatric illness in people with Prader\u2013Willi syndrome","volume":"38","author":"Soni","year":"2008","journal-title":"Psychol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/11\/9\/1197\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:00:49Z","timestamp":1760166049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/11\/9\/1197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["brainsci11091197"],"URL":"https:\/\/doi.org\/10.3390\/brainsci11091197","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]}}}